Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen.
D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood / Q000378:metabolism; D001925:Brain Damage, Chronic / Q000209:etiology; D001927:Brain Diseases / Q000209:etiology*; D002248:Carbon Monoxide / Q000096:biosynthesis; D004905:Erythrocyte Aging; D005260:Female; D005965:Glucuronates / Q000652:urine; D005984:Glutethimide / Q000627:therapeutic use; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D007208:Indocyanine Green; D007612:Kanamycin / Q000627:therapeutic use; D008111:Liver Function Tests; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D010789:Phototherapy; D010956:Plasmapheresis; D011485:Protein Binding; D011868:Radioisotopes; D006435:Renal Dialysis; D012457:Salicylamides / Q000378:metabolism; D013448:Sulfobromophthalein / Q000627:therapeutic use; D013577:Syndrome; D000637:Transaminases / Q000097:blood
D005965:Glucuronates; D011868:Radioisotopes; D012457:Salicylamides; D013448:Sulfobromophthalein; D007612:Kanamycin; D010672:Phenytoin; D002248:Carbon Monoxide; D005984:Glutethimide; D000637:Transaminases; D000469:Alkaline Phosphatase; D007208:Indocyanine Green; D001663:Bilirubin; D010634:Phenobarbital